SENSEONICS HOLDINGS INC (SENS) Stock Fundamental Analysis

NASDAQ:SENS • US81727U3032

8.27 USD
-0.08 (-0.96%)
At close: Feb 27, 2026
8.2007 USD
-0.07 (-0.84%)
After Hours: 2/27/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SENS. SENS was compared to 184 industry peers in the Health Care Equipment & Supplies industry. The financial health of SENS is average, but there are quite some concerns on its profitability. SENS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year SENS has reported negative net income.
  • SENS had a negative operating cash flow in the past year.
  • In the past 5 years SENS reported 4 times negative net income.
  • SENS had a negative operating cash flow in each of the past 5 years.
SENS Yearly Net Income VS EBIT VS OCF VS FCFSENS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

  • With a Return On Assets value of -45.57%, SENS is not doing good in the industry: 64.86% of the companies in the same industry are doing better.
  • SENS has a Return On Equity (-81.58%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -45.57%
ROE -81.58%
ROIC N/A
ROA(3y)-13.99%
ROA(5y)-136.34%
ROE(3y)-16.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SENS Yearly ROA, ROE, ROICSENS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K

1.3 Margins

  • SENS has a worse Gross Margin (41.11%) than 65.95% of its industry peers.
  • SENS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SENS Yearly Profit, Operating, Gross MarginsSENS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • SENS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, SENS has more shares outstanding
  • SENS has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for SENS is higher compared to a year ago.
SENS Yearly Shares OutstandingSENS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
SENS Yearly Total Debt VS Total AssetsSENS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • SENS has an Altman-Z score of -6.98. This is a bad value and indicates that SENS is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -6.98, SENS is doing worse than 71.89% of the companies in the same industry.
  • SENS has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.45, SENS is in line with its industry, outperforming 45.41% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z -6.98
ROIC/WACCN/A
WACC10.21%
SENS Yearly LT Debt VS Equity VS FCFSENS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

2.3 Liquidity

  • SENS has a Current Ratio of 6.23. This indicates that SENS is financially healthy and has no problem in meeting its short term obligations.
  • SENS has a better Current ratio (6.23) than 82.16% of its industry peers.
  • SENS has a Quick Ratio of 5.93. This indicates that SENS is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 5.93, SENS belongs to the best of the industry, outperforming 86.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.23
Quick Ratio 5.93
SENS Yearly Current Assets VS Current LiabilitesSENS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 37.31% over the past year.
  • The Revenue has grown by 31.94% in the past year. This is a very strong growth!
  • The Revenue has been growing slightly by 1.08% on average over the past years.
EPS 1Y (TTM)37.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.25%
Revenue 1Y (TTM)31.94%
Revenue growth 3Y18.01%
Revenue growth 5Y1.08%
Sales Q2Q%89.89%

3.2 Future

  • Based on estimates for the next years, SENS will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.91% on average per year.
  • SENS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 53.85% yearly.
EPS Next Y30.95%
EPS Next 2Y1.96%
EPS Next 3Y5.01%
EPS Next 5Y8.91%
Revenue Next Year59.44%
Revenue Next 2Y64.21%
Revenue Next 3Y61.77%
Revenue Next 5Y53.85%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SENS Yearly Revenue VS EstimatesSENS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M 400M 500M
SENS Yearly EPS VS EstimatesSENS Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • SENS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SENS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SENS Price Earnings VS Forward Price EarningsSENS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SENS Per share dataSENS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.96%
EPS Next 3Y5.01%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • SENS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SENSEONICS HOLDINGS INC

NASDAQ:SENS (2/27/2026, 8:00:02 PM)

After market: 8.2007 -0.07 (-0.84%)

8.27

-0.08 (-0.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05
Earnings (Next)03-02
Inst Owners15.44%
Inst Owner Change-82.68%
Ins Owners2.77%
Ins Owner Change0.13%
Market Cap337.91M
Revenue(TTM)29.30M
Net Income(TTM)-63.77M
Analysts75.71
Price Target19.3 (133.37%)
Short Float %11.52%
Short Ratio9
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-24.33%
Min EPS beat(2)-50.62%
Max EPS beat(2)1.96%
EPS beat(4)3
Avg EPS beat(4)0.04%
Min EPS beat(4)-50.62%
Max EPS beat(4)34.09%
EPS beat(8)6
Avg EPS beat(8)2.76%
EPS beat(12)7
Avg EPS beat(12)11.3%
EPS beat(16)10
Avg EPS beat(16)45.79%
Revenue beat(2)1
Avg Revenue beat(2)4.03%
Min Revenue beat(2)-0.18%
Max Revenue beat(2)8.25%
Revenue beat(4)3
Avg Revenue beat(4)5.46%
Min Revenue beat(4)-0.18%
Max Revenue beat(4)10.29%
Revenue beat(8)6
Avg Revenue beat(8)4.18%
Revenue beat(12)9
Avg Revenue beat(12)4.49%
Revenue beat(16)11
Avg Revenue beat(16)3.01%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0.33%
EPS NQ rev (3m)0.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.3%
Revenue NQ rev (1m)0.18%
Revenue NQ rev (3m)0.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.53
P/FCF N/A
P/OCF N/A
P/B 4.32
P/tB 4.37
EV/EBITDA N/A
EPS(TTM)-1.63
EYN/A
EPS(NY)-2.3
Fwd EYN/A
FCF(TTM)-1.37
FCFYN/A
OCF(TTM)-1.36
OCFYN/A
SpS0.72
BVpS1.91
TBVpS1.89
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -45.57%
ROE -81.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.11%
FCFM N/A
ROA(3y)-13.99%
ROA(5y)-136.34%
ROE(3y)-16.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 39.87%
Cap/Sales 2.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.23
Quick Ratio 5.93
Altman-Z -6.98
F-Score5
WACC10.21%
ROIC/WACCN/A
Cap/Depr(3y)70.29%
Cap/Depr(5y)48.74%
Cap/Sales(3y)4.48%
Cap/Sales(5y)3.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.25%
EPS Next Y30.95%
EPS Next 2Y1.96%
EPS Next 3Y5.01%
EPS Next 5Y8.91%
Revenue 1Y (TTM)31.94%
Revenue growth 3Y18.01%
Revenue growth 5Y1.08%
Sales Q2Q%89.89%
Revenue Next Year59.44%
Revenue Next 2Y64.21%
Revenue Next 3Y61.77%
Revenue Next 5Y53.85%
EBIT growth 1Y20.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year28.8%
EBIT Next 3Y-10.15%
EBIT Next 5YN/A
FCF growth 1Y22.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.55%
OCF growth 3YN/A
OCF growth 5YN/A

SENSEONICS HOLDINGS INC / SENS FAQ

Can you provide the ChartMill fundamental rating for SENSEONICS HOLDINGS INC?

ChartMill assigns a fundamental rating of 2 / 10 to SENS.


Can you provide the valuation status for SENSEONICS HOLDINGS INC?

ChartMill assigns a valuation rating of 0 / 10 to SENSEONICS HOLDINGS INC (SENS). This can be considered as Overvalued.


What is the profitability of SENS stock?

SENSEONICS HOLDINGS INC (SENS) has a profitability rating of 0 / 10.


What is the financial health of SENSEONICS HOLDINGS INC (SENS) stock?

The financial health rating of SENSEONICS HOLDINGS INC (SENS) is 4 / 10.